TVGN · Tevogen Inc.
AI read · Good for TVGN
The AI's read
This removes an obstacle to Tevogen remaining on Nasdaq. The filing reports no new sales, cash, or drug progress, so the benefit is limited to its listing status.
Tevogen regained compliance with Nasdaq's continued-listing requirement, and the matter is closed. This eases a threat to its listing, though the filing reports no new business or drug progress.
This removes an obstacle to Tevogen remaining on Nasdaq. The filing reports no new sales, cash, or drug progress, so the benefit is limited to its listing status.
Follow Tevogen Inc. (TVGN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TVGN